The chair of the TSRI Board of Trustees reaches out to the institute’s faculty, staff, supporters and friends.
Research from the Schimmel lab has uncovered a previously unrecognized layer of biology that could offer new drug targets.
The discovery from the Kishi lab could lead to using therapeutics, even some commonly used ones, to manipulate the aging process itself.
“Our research has relevance to pain, but also to many other biological processes, such as controlling blood pressure, atherosclerosis and glaucoma,” says Professor Ardem Patapoutian.
Associate Professor Christoph Rader will be the principal investigator for the new five-year study.